These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 17728023)
1. Long lasting BCG protection against leprosy. Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023 [TBL] [Abstract][Full Text] [Related]
2. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973 [TBL] [Abstract][Full Text] [Related]
3. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children. Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320 [TBL] [Abstract][Full Text] [Related]
4. BCG vaccination protects against leprosy in Venezuela: a case-control study. Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026 [TBL] [Abstract][Full Text] [Related]
5. [The protective efficacy of BCG against leprosy in São Paulo, Brazil]. Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil. Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924 [TBL] [Abstract][Full Text] [Related]
8. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya. Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Zodpey SP; Ambadekar NN; Thakur A Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132 [TBL] [Abstract][Full Text] [Related]
10. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study. Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442 [TBL] [Abstract][Full Text] [Related]
11. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy. Velema JP; Ogbeiwi OI Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479 [TBL] [Abstract][Full Text] [Related]
12. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891 [TBL] [Abstract][Full Text] [Related]
13. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275 [TBL] [Abstract][Full Text] [Related]
14. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis. Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701 [TBL] [Abstract][Full Text] [Related]
15. Comparative leprosy vaccine trial in south India. Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India. Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357 [TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of BCG against leprosy in São Paulo. Lombardi C; Pedrazzani ES; Pedrazzani JC; Filho PF; Zicker F Bull Pan Am Health Organ; 1996 Mar; 30(1):24-30. PubMed ID: 8919722 [TBL] [Abstract][Full Text] [Related]
18. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India. Rahete NP; Zodpey SP; Kamble KM Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467 [TBL] [Abstract][Full Text] [Related]
20. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]